New Enterprise Associates

New Enterprise Associates is a venture capital firm that invests in technology and healthcare startups. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. The company focuses on the technology and healthcare industries.

Kate Barrett

Partner, Communications

Peter Barris

Chairman

Forest Baskett

General Partner

Ali Behbahani

General Partner

Philip Chopin

Managing Director, NEA UK

Jay Graf

Venture Partner

Patrick Kerins

General Partner

Nick Kline

Principal, LP Relations

Tiffany Luck

Partner

Mohamad Makhzoumi

General Partner

Amit Mukherjee

Partner

Bibhash Mukhopadhyay

Principal

Greg Papadopoulos

Venture Partner

Justine Potemkin

Associate

Jai Sajnani

Principal

Scott Sandell

Managing General Partner

Tim Schaller

CFO

Andrew Schoen

Partner

Alex Sharata

Associate

Blake Wu

Partner

Emily Zhen

Associate

2033 past transactions

Union.ai

Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

Orby AI

Seed Round in 2023
Orby AI is an AI platform designed to bring the auto-complete experience to everyday business users and automate all mundane tasks. Orby monitors a user's activity, finds recurring work steps, and develops code that eventually automates these jobs.

Kira

Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Magenta Medical

Venture Round in 2023
Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

SimpleRose

Venture Round in 2023
SimpleRose is a technology company that allows customers to optimize and accelerate decision-making. The company's applications include scheduling, production planning, and portfolio optimization.

Mojo Vision

Series C in 2023
Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full-color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Fabric8Labs

Series B in 2023
Fabric8Labs developed a unique process that is an intuitive combination of two mature technologies: Stereo-Lithography and Electro-Deposition.

Flox

Series A in 2023
Flox is taking nix to work on building software and managing development environments. The company was founded by Michael Brantley and Ron Efroni in 2018 and is headquartered in New York, United States.

Bliq

Series A in 2022
Bliq helps gig workers in the transport industry to automate the organization of their daily work. The “Bliq Ride” app allows registered drivers to accept or reject orders from multiple platforms. Bliq was founded in 2019 by Julian Glaab (CEO), Johannes Riedel (COO), and Torgen Hauschild (CTO). The company is based in Berlin and currently employs 25 people.

Everside Health

Venture Round in 2022
Everside Health is a direct primary care provider offering convenient on-site, near-site, and virtual care for its members. Everside’s data-driven, patient-centric healthcare delivery model aligns incentives to benefit the patient, the physician, and the benefit provider, all while reducing the total cost of care. Everside Health was founded in 2010 and is based in Denver, Colorado.

DeltaStream

Seed Round in 2022
DeltaStream is a unified self-service stream processing platform that gives you all the power of Apache Flink with the ability to build materialized views. With impressive features like data governance, unified views, 3rd party sharing, private SaaS, and query level scaling - it’s your operational dream come true. Efficiently addresses streaming analytics and streaming database use cases, with limitless scalability to meet your needs. Enable your entire organization to harness the power of your streaming data.

Gossamer Bio

Post in 2022
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

Change

Seed Round in 2022
CHANGE is a platform that powers the giving economy. Brands add a button to checkout, and we do the rest. With CHANGE, brands eliminate the time and resources spent on connecting, vetting, and integrating with nonprofits. The platform streamlines corporate giving, provides real-time analytics, and actively engages the most coveted demographic with shareable content.

X4 Pharmaceuticals

Post in 2022
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinoma (ccRCC) and refractory epithelial ovarian cancer (EOC), the second program, X4P-002, is a unique series of late lead molecules that penetrate the blood-brain barrier. They will pursue early clinical development in glioblastoma multiforme (GBM), a rare form of lethal brain cancer, for the X4P-002 program.

AI Squared

Seed Round in 2022
AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.

Narmi

Series B in 2022
Narmi is a provider of mobile, online, and digital account banking to regional and community financial institutions. Its platform enables financial institutions to open accounts in less than 2.5 minutes, and then grow that relationship over a lifetime through intuitive mobile and online channels.

Arkestro

Series A in 2022
Arkestro is a predictive procurement software for businesses to boost savings and supply chain performance by pre-embedding preferred outcomes in any system or process. With Arkestro, businesses can orchestrate their activities across systems using instant forecasts and real-time collaboration. Predict and win 2–5x faster savings and never get stuck waiting for a KPI report again.

Echodyne

Series D in 2022
Echodyne develops and manufactures meta-materials-based radar technologies. The company combines the patented technology of metamaterials with powerful software to create a radar sensor with unprecedented performance at commercial price points. Echodyne's patented technology and powerful software create a high-performance radar platform that produces security and machine autonomy solutions for government, defense, and industry. The company was founded in 2014 and is headquartered in Kirkland, Washington.

Lily AI

Venture Round in 2022
Lily AI is the first platform that bridges the gap between brand-speak and customer-speak to drive exponential growth for commerce companies large and small. Lily AI seamlessly injects customer-centric product attributes into site search engines, recommendation systems, SEO/SEM capabilities and item setup processes to drive exponential lifts in traffic, conversion, revenue and brand loyalty. The company is venture-backed and headquartered in Mountain View, CA.

Senti Biosciences

Post in 2022
Senti Biosciences is a biotechnology company focused on synthetic biology and gene circuit engineering for therapeutic applications. Senti Bio utilizes a synthetic biology platform named Gene Circuits to develop therapies that offer improved precision and control. These circuits are engineered to selectively eliminate cancer cells while sparing healthy ones, enhancing specificity for target cells, and regulating drug expression post-administration.

Kira

Seed Round in 2022
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Super

Series C in 2022
Super is a social commerce platform that enables leaders to become self-made entrepreneurs and builds logistics networks. The company features Superagen, an agent-led commerce group buying that enables community leaders to become retailers within their communities.

Celcuity

Post in 2022
Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies.

Bliq

Series A in 2022
Bliq helps gig workers in the transport industry to automate the organization of their daily work. The “Bliq Ride” app allows registered drivers to accept or reject orders from multiple platforms. Bliq was founded in 2019 by Julian Glaab (CEO), Johannes Riedel (COO), and Torgen Hauschild (CTO). The company is based in Berlin and currently employs 25 people.

Graft

Pre Seed Round in 2022
Graft is a Modern AI platform enabling data teams to build production-ready AI solutions in a few clicks. No machine learning skills, no need to hire a team, and no infrastructure to build or maintain. Take a data-centric approach that leverages foundation models to drive better business outcomes today.

Mashgin

Series B in 2022
Mashgin's A.I. based self-checkout system can be deployed in a matter of minutes and at the fraction of the cost of Amazon Go. This system is already deployed across hundreds of locations and is used by tens of thousands of people every day. Mashgin was founded in 2014 and is based in Palo Alto, California.

Sentry

Series E in 2022
Sentry is an open-source platform for workflow productivity, aggregating data from errors and crashes across the stack. The company's tool shows every crash in the stack as it happens, with the details needed to prioritize and identify it, as well as offers insight into deployments and information to reproduce and fix crashes, enabling users to see which errors are doing the most harm to their business and helps them to understand how issues affect their bottom line.

Wheelhouse

Series A in 2022
Wheelhouse is a business intelligence platform that helps turn the hosts & owners into superheroes. We're proud that thousands of hosts & owners have used our flagship product, data-driven pricing, to earn significantly more revenue from their business. We're a team of YC alums, data science PhD's, hedge fund engineers, product evangelists, and hustlers. Our teams core values are "empowered together" and "seriously fun". We think that captures the mood & values of a team that works exceptionally well together, pushes the envelope, and is not against cracking a beer together around 5pm on Friday. See more team members here: - https://angel.co/usewheelhouse - https://www.usewheelhouse.com/about-us

Union.ai

Seed Round in 2022
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

NODAR

Series A in 2022
NODAR develops a camera-based 3D vision system for autonomous vehicles that provides unprecedented accuracy. The safety of these vehicles depends on the reliability and performance of their 3D sensors. NODAR is building the next generation of camera-based 3D vision technology that delivers the performance, reliability, and price required by mainstream automotive.

Genies

Series C in 2022
Genies is culture’s leading avatar technology company empowering humans to create their own avatar experiences. To-date, Genies has been widely adopted by cultural tastemakers and has partnerships with Universal Music Group and Warner Music Group as their rosters’ “official avatar.” Genies has recently launched its consumer arm via its AR Developer Kit which allows developers to create interoperable avatar experiences for mobile and hardware AR. Their first avatar experience, Silver Studio, allows users to design and exchange digital fashion. Genies has raised $250M from investors such as Silver Lake, BOND, NEA, and Bob Iger valuing the company at $1 billion.

Trevi Therapeutics

Post in 2022
Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF), and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.

Evernow

Series A in 2022
Evernow is a provider of women's health care services before, during, and after menopause. Their platform has online access to specialized doctors, science-backed information, and treatments, along with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.

Antimatter

Series A in 2022
Antimatter is a cryptographic infrastructure service enabling B2B SaaS companies to provably guarantee the security of their customers' data, fundamentally solving the challenges of data security and privacy requirements without requiring any changes to code. Antimatter was founded in 2021 and is based in Oakland, California.

Clockwork Systems

Series A in 2022
Clockwork Systems is a technology enables next generation time-sensitive applications in on-prem data centers, public clouds, and hybrid environments.

SafeBase

Series A in 2022
SafeBase develops a smart trust center platform for sharing security posture and automating access to sensitive documents for enterprise programs. Its software offers custom security checklists, and continuous monitoring of security systems, and configures security policies to allow companies to implement security practices.

Beyond Identity

Series C in 2022
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

Timescale

Series C in 2022
Timescale is the modern cloud platform built on PostgreSQL for time-series, events and analytics. Timescale is dedicated to serving software developers and businesses worldwide, enabling them to build the next wave of computing. Timescale has a global workforce and is backed by Benchmark, New Enterprise Associates, Redpoint, Icon, Tiger Global, Two Sigma Ventures, and other leading investors. For more information, visit www.timescale.com or follow @TimescaleDB.

Cohere Technologies

Series D in 2022
Cohere Technologies is a leading pioneer for software enhanced 4G & 5G networks. The company has developed a 3GPP compliant software solution to dramatically improve today’s 4G and 5G networks. Cohere is the inventor of OTFS for 6G. Founded in 2009, Cohere Technologies is headquartered in San Jose, California.

Uniphore

Series E in 2022
Uniphore develops tools that facilitate customer interactions through speech recognition, natural language processing, and sentiment analysis. It integrates with various communication channels to support customer service operations. Uniphore focuses on enabling businesses to analyze conversations.

Splice Bio

Series A in 2022
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

Branch

Series F in 2022
Branch is the linking and measurement partner for growth-focused teams, trusted to maximize the value of their evolving digital strategies. World-class brands like Instacart, Western Union, NBCUniversal, Zocdoc and Sephora rely on Branch to acquire users, retain customers and drive more conversions.

hOS

Seed Round in 2022
HOS is an AI technology company that develops scalable technologies to achieve significant and constructive changes in the world.

Neo Cybernetica

Seed Round in 2022
Neo Cybernetica develops cybernetics technology to improve the capability of artificially intelligent systems in achieving both autonomously and in collaboration with humans.

Thunkable

Series B in 2022
From MIT's App Inventor and YCombinator's W2016 batch, Thunkable allows anyone to build powerful native apps. With Thunkable, it's simple to design, and simple to code-- simply drag and drop to create fast, native, reliable apps. You don't need to download large development suites, command-line kits, or simulators. You can use the many built-in app templates as they are, or make changes. Make your changes online and see them on your device instantly with the Thunkable mobile app. Upload your apps directly to the Play Store or send them to friends!

HackerOne

Series E in 2022
HackerOne, founded in 2012 and headquartered in San Francisco, develops a hacker-powered security platform that connects businesses with penetration testers and cybersecurity researchers. The platform facilitates bug bounty solutions, enabling organizations to mitigate security risks through collaboration with a global community of ethical hackers. It promotes a coordinated approach to vulnerability disclosure and response, allowing companies to manage and address security vulnerabilities effectively. By partnering with the hacker community, HackerOne helps organizations identify and resolve relevant security issues before they can be exploited by malicious actors, ultimately enhancing consumer trust and protecting sensitive data. The company also has offices in London, New York City, Singapore, and the Netherlands.

Virtru

Series C in 2022
Virtru empowers organizations to easily unlock the power of data while maintaining control, everywhere it’s stored and shared. Creators of TDF (Trusted Data Format), the open industry standard for persistent data protection, Virtru provides flexible, easy to use, and trusted privacy technologies built on its data protection platform that govern access to data throughout its full lifecycle—from creation to transmission, storage, analysis, and sharing. More than 20,000 organizations of every size and industry trust Virtru for data security and privacy protection. Virtu was established in 2012 and is based in Washington, District of Columbia.

Smartcar

Series B in 2022
Smartcar enables mobility businesses to integrate their apps and services with connected cars. Easily retrieve vehicle data and trigger actions with our simple and secure car API. Track vehicle location, manage EV charging, verify mileage, lock & unlock remotely, and more. Our developer-friendly documentation and SDKs allow you to quickly integrate our car API with every tech stack.

Kira

Pre Seed Round in 2022
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Proof of Learn

Seed Round in 2022
Proof of Learn is the talent marketplace for nextgen devs - educating, upskilling and placing nextgen talent.. The company operates Metacrafters.io, a multichain learn-to-earn game that teaches users to write smart contracts and build on-chain. It was founded in 2021 and is based in Boston, MA.

Nitra

Seed Round in 2022
Nitra’s mission is to overhaul the healthcare industry with radically efficient and transparent solutions. Nitra empowers providers to find the right balance between supporting their patients and running their practice – starting with tools that deliver a simpler, smarter way to manage their spending. With Nitra’s finance tools, we empower our members to manage payments in one place, and get a clear overview of day-to-day spending. The Nitra Visa Business Card, unlocks rewards each time they spend, and provides discounts with a diverse network of partners. Accounting and receipt reconciliation is simple and speedy, powered by innovative, human-friendly technology. We believe the healthcare sector deserves the latest technology and the most committed support. If it can be better, it should be.

Aquabyte

Venture Round in 2022
Aquabyte builds machine-learning products for aquaculture (fish) farms. Aquabyte was founded in 2017 to bring machine learning and computer vision technologies to the aquaculture industry. The company's diverse team of machine learning experts, entrepreneurs, and aquaculture biologists are hyperfocused on delivering solutions with a real-world impact. Real-time sea lice counting, biomass monitoring, and appetite detection are just a few of the many applications that will eventually be possible with the Aquabyte system. Aquabyte surpasses modern farm monitoring products with our machine-learning platform and smart camera system. The company's solution offers easy installation, continuous monitoring, and multiple applications. Aquabyte’s mission is to use machine learning to make fish farms more efficient, sustainable, and profitable.

Korro Bio

Series B in 2022
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,

Mojo Vision

Series B in 2022
Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full-color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Aigen

Seed Round in 2022
Aigen is connecting farmers to breakthrough technologies, decarbonizing agriculture, and improving human and planetary health. The company is developing an autonomous, solar-powered robotics platform that manages plants without the chemical inputs that undermine soil's carbon storage potential by bringing alternatives to conventional practices, allowing farmers to regenerate soil health and deal with the global agriculture manual labor shortage.

InCarey

Series C in 2021
InCarey is a leading domestic comprehensive service platform focusing on the management of patients with chronic diseases and vertical diseases. It is committed to providing one-stop Internet medical, pharmaceutical, and medical services for patients with long-term, heavy-service, and high-value chronic diseases. Innovative payment services.

Yumi

Series B in 2021
Yumi is the definitive source for parents seeking to understand what they are feeding their children and why, offering a science-based early childhood meal delivery program that is the most convenient and most nutritional option in the market.

Forethought

Series C in 2021
Launched in 2018, Forethought is a generative AI for customer service automation to maximize efficiency and productivity. Forethought’s products enable seamless customer experiences by infusing generative AI, powered by Large Language Models (LLMs), at each stage of the customer support journey: resolving common cases instantly, predicting and prioritizing cases, and assisting agents with relevant knowledge—all from one platform.

Belong Health

Series A in 2021
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.
Simple psychology belongs to Beijing Zhujian Technology Co., Ltd. Simple psychology focuses on providing high-quality psychological services.

UNION

Series B in 2021
Union, an all-in-one hospitality engagement platform, leverages industrial grade data intelligence to deliver transformative experiences for the industry’s most popular venues, their guests, and their brand partners.

Wonder

Series A in 2021
Wonder is a gaming company focused on creating an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across various devices, thereby enhancing the overall gaming experience. In addition to its software solutions, Wonder is also involved in developing VR-ready gaming hardware. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be working on innovative features or products.

Anyscale

Series C in 2021
Anyscale, the company founded by the creators of Ray, is accelerating the development and productionization of AI applications, at any scale. Ray, the fastest growing open source project in distributed AI, lets developers instantly scale applications from a laptop to the cloud, without the cost or expertise of building complex infrastructure. By empowering developers of all skill levels to effortlessly develop and scale the end-to-end AI lifecycle on a single compute substrate and deploy the app into production, Anyscale is enabling organizations to bring AI products to market faster and at lower costs. Backed by Andreessen Horowitz, NEA, and Addition, Anyscale is based in San Francisco, CA. www.anyscale.com

Neuehealth

Post in 2021
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.

AviadoBio

Series A in 2021
AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.

Recludix Pharma

Series A in 2021
Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.

Datafold

Series A in 2021
Datafold builds tools for automating analytical data quality management. It helps companies extract more value from their analytical data by automating Data Engineering workflows like data quality monitoring. It also simplifies data QA by enabling instant table comparison and profiling.

Block Renovation

Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Merge

Series A in 2021
Merge is one API to add hundreds of integrations to your product. Merge’s platform makes secure data access easy by offering Unified APIs across key software categories, including HRIS, accounting, CRM, file storage, and more. Merge handles the full integrations lifecycle — from an easy initial build taking just weeks, to providing integration observability tools ensuring customer delight, and fully owning the maintenance of integrations. Thousands of companies use Merge to power their integrations, enabling them to unblock sales, reduce customer churn, accelerate time to market for new products, and save engineering costs and resources. Merge is backed by $75 million in funding from Accel, NEA, and Addition. Merge was founded in 2020 by Shensi Ding and Gil Feig and is proudly built in San Francisco, New York City, and Berlin.

Contra

Series B in 2021
Contra is a networking platform that gives users the freedom and opportunity to work independently. It provides flexible work opportunities from people through an exclusive community and referral network by showcasing work portfolios that enable freelancers and other independent professionals to earn a living on their own terms. The San Francisco, California-based company was established in 2019 by Ben Huffman and Gajus Kuizinas.

Kiswe

Venture Round in 2021
Kiswe connects at-home viewers with live events and in-venue fans through interactive video experiences that create memorable social experiences and build loyalty. Kiswe’s video production solution, Kiswe Studio uses cloud-based technology to transform the way live games and events are professionally produced and broadcasted. The Kiswe suite of solutions is used by the world’s largest broadcasters, media companies, sports and eSports leagues, and music labels, including Big Hit Entertainment (BTS), NBA, Globo, MLS, PGA Tour, Turner Sports, and many more. Kiswe is headquartered in the U.S. and has offices in Europe and Asia.

Attest

Series B in 2021
Attest is a fast-scaling, SaaS business based in London and New York, and backed by investors including NEA, one of Silicon Valley's most prolific venture capital firms with over 225 portfolio company IPOs since 1977. Attest is a consumer research platform that delivers consumer data that drive predictable and repeatable growth to businesses. The Attest platform enables businesses to engage directly with >110 million consumers across >45 countries, starting in 90 seconds. Attest enables businesses to learn, measure, and grow ever-faster, across marketing, product, brand, innovation, competition, pricing, and beyond. Great companies put consumers and data at the heart of every decision. Attest makes this possible for anyone in any business, continuously, on a global scale. Clients use Attest to crack their greatest growth problems and fill the most valuable gaps in their knowledge, informing real decisions with fresh new inputs every day.

Stride Health

Series C in 2021
Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services. Everyone deserves a smart way to protect your health – and your wallet – without breaking a sweat. That’s why we do the tricky calculus for you. In minutes we’ll enroll you in your most cost-effective health plan, minimize your taxes and maximize your take-home pay as an independent worker or part-time employee. If that wasn’t enough, our personal advisors will navigate the details for you whenever you need us!

Candy

Series A in 2021
Candy is a multifaceted company that operates in the digital collectible and confectionery sectors. It develops sports and culture digital assets, providing authentic digital experiences that engage fans and connect them with their interests. Additionally, Candy.com serves as an online retailer catering to the growing demand for bulk, gourmet, and gift confectionery products, offering competitive pricing, expedited shipping, and a unique shopping experience. Furthermore, Candy Digital specializes in non-fungible tokens (NFTs), enabling fans to buy and trade officially licensed tokens related to Major League Baseball. Launched in 2021, this segment of the business was established by notable figures in the industry and reflects Candy's commitment to integrating technology with fan engagement.

Clarifai

Series C in 2021
Clarifai is a leading, full-lifecycle deep learning AI platform for computer vision, natural language processing, and audio recognition. We help organizations transform unstructured images, video, text, and audio data into structured data at a significantly faster and more accurate rate than humans would be able to do on their own. Founded in 2013 by Matt Zeiler, Ph.D. Clarifai has been a market leader in AI since winning the top five places in image classification at the 2013 ImageNet Challenge. Clarifai continues to grow with employees remotely based throughout the United States, Canada, Estonia, Argentina & India.

Slope.io

Series A in 2021
Slope connects a clinical trial to its supply chain, coordinating the operational complexity of getting devices, drugs, & kits from suppliers to sites to patients in real-time with complete traceability.

Wizard

Series A in 2021
Wizard is a software development company that offers B2B solutions for brands to sell and market products directly through text.

Neural Magic

Series A in 2021
Neural Magic specializes in enterprise inference solutions that optimize the performance of open-source large language models (LLMs) across various infrastructures. The company focuses on maximizing computational efficiency and hardware utilization, enabling organizations to deploy AI models securely and cost-effectively.

Inkitt

Series B in 2021
We're building the Disney of the 21st century, creating blockbuster franchises across all media: from text, audiobooks, movies, to theme parks. Our success is most notable in e-books, where we are producing million-dollar hits every month through data-driven story selection and AI optimization. Our ecosystem includes three interconnected apps: - Inkitt: A social reading/writing platform with half a million active authors and millions of readers. - Galatea: Sells optimized stories chapter by chapter. - GalateaTV: Transforms successful e-books into short-form TV series, selling episodes individually. Our proprietary ReadRank algorithm predicts bestsellers, with top stories moving to Galatea. We launch a new TV series weekly. Our future focus is on Hyper Personalisation, adapting stories to individual preferences across all formats using AI.

Sisu

Series C in 2021
Sisu is a decision intelligence engine that allows users to efficiently and comprehensively utilize their cloud data. Companies such as Mastercard, Autodesk, Samsung, Upwork, Wayfair, Equinox, Udacity, and Gusto leverage Sisu to enhance their customer experiences, increase revenue growth, and reduce incident rates.

Pager

Series C in 2021
Pager’s mission is to help people make better healthcare decisions by increasing access, decreasing costs, and making care easier to understand. Pager provides a flexible, embeddable platform for health plans and systems to better serve consumers with information, guidance, and coordination. By bringing AI-augmented care and service teams together, Pager’s platform unsilos and provides services such as triage, telemedicine, appointment scheduling, prescription refills, health advocacy, and care coordination – creating a unified, concierge experience like having a “doctor in your family”. Pager supports more than 15 million covered lives across the United States and Latin America. www.pager.com

858 Therapeutics

Series A in 2021
858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology. The company emphasizes innovative approaches in synthetic lethality, innate immunity, and RNA modulation. Its lead program is a PARG inhibitor currently in early clinical development.

Allay Therapeutics

Series C in 2021
Allay is pioneering a new category of ultra-sustained pain therapeutics to transform post-surgical pain management and recuperation for patients and physicians. Allay’s proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable therapeutics to deliver pain relief within a targeted site over weeks—an order of magnitude greater than the longest-lasting pain treatments currently available. The company’s lead investigational product candidate, ATX101, is currently being evaluated in a Phase 2 clinical study in TKA surgeries. Allay unites a dynamic, global team of entrepreneurs, scientists, clinicians and innovators in the San Francisco Bay Area and Singapore.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.